|
Transcripts of coding genes that showed significantly decreased expression in muscle. |
DESeq2 (version 1.24.0). Transcripts with a false-discovery rate adjusted p-value less than 0.05 were considered significantly differentially expressed. |
WBPaper00062325:muscle_depleted_coding-RNA
|
|
Neuronally enriched transcripts according to a comparison of neuronal nuclei IP samples to total nuclei using isolation of nuclei from tagged specific cell types (INTACT) technology. |
DESEQ2, fold change > 2 and FDR < 0.01. |
WBPaper00062103:neuron_enriched
|
|
Transcripts expressed in intestine, according to PAT-Seq analysis using Pges-1-GFP-3XFLAG mRNA tagging. |
Cufflinks FPKM value >=1. |
WBPaper00050990:intestine_expressed
|
|
Transcripts expressed in pharynx, according to PAT-Seq analysis using Pmyo-2-GFP-3XFLAG mRNA tagging. |
Cufflinks FPKM value >=1. |
WBPaper00050990:pharynx_expressed
|
|
Transcripts that showed significantly altered expression at URX, AQR, and PQR neurons in camt-1(ok515) animals comparing to in wild type AX1888-1 strain. |
RNA-seq data were mapped using PRAGUI - a Python 3-based pipeline for RNA-seq data analysis. |
WBPaper00061902:camt-1(ok515)_regulated_URX-AQR-PQR
|
|
Transcripts that showed significantly decreased expression in eat-2(ad1116) comparing to in N2 at 3-days post L4 adult hermaphrodite animals. |
DESeq2(v1.14.1), fold change > 2, p-value < 0.05 |
WBPaper00055354:eat-2(ad1116)_downregulated
|
|
Transcripts that showed significantly decreased expression after animals were treated with 100uM Rapamycin and 50uM Rifampicin from day 1 to day 3 adult hermaphradite. |
DESeq2(v1.14.1), fold change > 2, p-value < 0.05 |
WBPaper00055354:Rapamycin-Rifampicin_downregulated
|
|
Transcripts that showed significantly decreased expression in whole animal day 1 N2 adults comparing to in whole animal day 8 N2 adults. |
DESeq2, FDR < 0.05, fold change > 2. |
WBPaper00066978:Day1Adult_vs_Day8Adult_downregulated_neuron
|
|
Transcripts that showed significantly decreased expression after animals were treated with 100uM Rapamycin, 50uM Rifampicin and 250uM Allantoin from day 1 to day 3 adult hermaphradite. |
DESeq2(v1.14.1), fold change > 2, p-value < 0.05 |
WBPaper00055354:Rapamycin-Rifampicin-Allantoin_downregulated
|
|
Transcripts that showed significantly decreased expression after animals were treated with 50uM Rifampicin and 100uM Psora from day 1 to day 3 adult hermaphradite. |
DESeq2(v1.14.1), fold change > 2, p-value < 0.05 |
WBPaper00055354:Rifampicin-Psora_downregulated
|
|
Transcripts that showed significantly decreased expression after animals were treated with 100uM Rapamycin, 50uM Rifampicin and 100uM Psora from day 1 to day 3 adult hermaphradite. |
DESeq2(v1.14.1), fold change > 2, p-value < 0.05 |
WBPaper00055354:Rapamycin-Rifampicin-Psora_downregulated
|
|
Transcripts that showed significantly decreased expression after animals were treated with 100uM Rapamycin, 100uM Psora and 250uM Allantoin from day 1 to day 3 adult hermaphradite. |
DESeq2(v1.14.1), fold change > 2, p-value < 0.05 |
WBPaper00055354:Rapamycin-Psora-Allantoin_downregulated
|
|
Single-cell RNA-Seq cell group 115_0 expressed in neuron. |
scVI 0.6.0 |
WBPaper00065841:115_0
|
|
Top 300 transcripts enriched in RIVL, RIVR according to single cell RNAseq. |
Top 300 enriched transcripts were determined by log2.ratio of the tpm in the cell type vs the tpm in the other cells * the log2 of the cell.type tpm. |
WBPaper00061340:RIV
|
|
Top 300 transcripts enriched in AIAL, AIAR according to single cell RNAseq. |
Top 300 enriched transcripts were determined by log2.ratio of the tpm in the cell type vs the tpm in the other cells * the log2 of the cell.type tpm. |
WBPaper00061340:AIA
|
|
Single-cell RNA-Seq cell group 29_0 expressed in neuron. |
scVI 0.6.0 |
WBPaper00065841:29_0
|
|
Single-cell RNA-Seq cell group 97_0 expressed in neuron. |
scVI 0.6.0 |
WBPaper00065841:97_0
|
|
Single-cell RNA-Seq cell group 104_0 expressed in neuron. |
scVI 0.6.0 |
WBPaper00065841:104_0
|
|
Transcripts that showed significantly decreased expression in adr-1(tm668) comparing to in N2. |
DESeq2, p-value < 0.05 and a fold enrichment log2fold > 0.5. |
WBPaper00055226:adr-1(tm668)_downregulated
|
|
Single-cell RNA-Seq cell group 134_0 expressed in neuron. |
scVI 0.6.0 |
WBPaper00065841:134_0
|
|
Single-cell RNA-Seq cell group 38_1 expressed in muscle. |
scVI 0.6.0 |
WBPaper00065841:38_1
|
|
Transcripts enriched in SMB according to single cell RNAseq. |
Genes that pass the Bonferroni threshold for multiple comparisons (q < 0.05) are significantly enriched. |
WBPaper00061651:SMB_enriched
|
|
Single-cell RNA-Seq cell group 17_0 expressed in neuron. |
scVI 0.6.0 |
WBPaper00065841:17_0
|
|
Transcripts that showed significantly increased expression in WD483[kri-1(ok1251); mpk-2(ok219)] comparing to in N2. |
N.A. |
WBPaper00056586:kri-1(ok1251);mpk-2(ok219)_upregulated
|
|
Transcripts enriched in AIB according to single cell RNAseq. |
Genes that pass the Bonferroni threshold for multiple comparisons (q < 0.05) are significantly enriched. |
WBPaper00061651:AIB_enriched
|
|
Transcripts enriched in SAA according to single cell RNAseq. |
Genes that pass the Bonferroni threshold for multiple comparisons (q < 0.05) are significantly enriched. |
WBPaper00061651:SAA_enriched
|